Damora Therapeutics (DMRA) Interest Expenses (2019 - 2026)
Damora Therapeutics (DMRA) posted Interest Expenses of $11.4 million for Q1 2026, up 228331.6% on a QoQ basis from $5000.0 in Q4 2025, and up 12879.07% year-over-year from N/an in Q1 2025.
Damora Therapeutics (DMRA) Interest Expenses (2019 - 2026) Analysis & Trends
Damora Therapeutics' Interest Expenses history runs 8 years deep, the most recent figure standing at $11.4 million for Q1 2026.
- Quarterly Interest Expenses rose 12879.07% year-over-year to $11.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.4 million (up 12879.07% YoY) and the FY2025 annual result came in at $75.4 million, up 12.2% from the prior year.
- Interest Expenses was $11.4 million for Q1 2026 at Damora Therapeutics, up from $5000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $11.4 million in Q1 2026 and bottomed at $5000.0 in Q4 2025.
- A 5-year average of $1.0 million and a median of $120000.0 in 2022 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2024 — Interest Expenses slumped 98.53% — and 2026, when it soared 12879.07%.
- Damora Therapeutics' Interest Expenses stood at $155000.0 in 2022, then grew by 10.32% to $171000.0 in 2023, then plunged by 80.7% to $33000.0 in 2024, then slumped by 84.85% to $5000.0 in 2025, then surged by 228331.6% to $11.4 million in 2026.
- Business Quant data shows DMRA's Interest Expenses at $11.4 million in Q1 2026, $5000.0 in Q4 2025, and $20000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Damora Therapeutics | 986.02 Mn | 783.62 Mn | - | 11.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.42 Mn |
| Mar 31, 2026 | 11.42 Mn |
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 20,000.00 |
| Sep 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 89,000.00 |
| Jun 30, 2025 | 89,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Dec 31, 2024 | 33,000.00 |
| Dec 31, 2024 | 33,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Jun 30, 2024 | 48,000.00 |
| Jun 30, 2024 | 48,000.00 |
| Mar 31, 2024 | 92,000.00 |
| Mar 31, 2024 | 92,000.00 |
| Dec 31, 2023 | 171,000.00 |
| Dec 31, 2023 | 171,000.00 |